Trials / Completed
CompletedNCT00165867
An Open Label Phase II Study of Indisulam in Combination With Irinotecan in Patients With Metastatic Colorectal Cancer Who Have Been Previously Treated With 5-Fluorouracil/Leucovorin and Oxaliplatin
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 40 (planned)
- Sponsor
- Eisai Limited · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The overall purpose of this study is to determine the efficacy, safety and tolerability of indisulam in combination with irinotecan as a treatment for patients with metastatic colorectalcancer previously treated with 5-fluorouracil/leucovorin and oxaliplatin (FOLFOX).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | E7070 |
Timeline
- Start date
- 2005-04-01
- First posted
- 2005-09-14
- Last updated
- 2006-10-09
Locations
7 sites across 2 countries: France, United Kingdom
Source: ClinicalTrials.gov record NCT00165867. Inclusion in this directory is not an endorsement.